Published in Virchows Arch on October 12, 2005
Giant cell tumor of bone in elderly patients: a study of ten patients. Iowa Orthop J (2009) 0.96
Giant Cell Tumor Bone in an Elderly Male- an Unusual Case Misdiagnosed on MRI as a Malignant Sarcoma. Indian J Surg Oncol (2015) 0.76
Giant-cell tumour of bone. J Bone Joint Surg Br (2004) 2.48
Trisomies 8 and 20 in desmoid tumors. Cancer Genet Cytogenet (1996) 1.61
Cutaneous malignant melanoma and familial dysplastic nevi: evidence for autosomal dominance and pleiotropy. Am J Hum Genet (1986) 1.39
The origin of the neoplastic stromal cell in giant cell tumor of bone. Hum Pathol (2003) 1.27
Cytogenetic-morphologic correlations in aneurysmal bone cyst, giant cell tumor of bone and combined lesions. A report from the CHAMP study group. Mod Pathol (2000) 1.18
A subgroup of malignant fibrous histiocytomas is associated with genetic changes similar to those of well-differentiated liposarcomas. Cancer Genet Cytogenet (2002) 1.17
Telomeric fusion is a major cytogenetic aberration of giant cell tumors of bone. Pathology (1999) 0.94
Cytogenetic findings and biologic behavior of giant cell tumors of bone. Cancer (1990) 0.86
Cytogenetic findings in benign cartilaginous neoplasms. Cancer Genet Cytogenet (2003) 0.86
Molecular analysis of primary and recurrent giant cell tumors of bone. Cancer Genet Cytogenet (2005) 0.85
Novel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics. Am J Pathol (2001) 0.85
Molecular delineation of the commonly deleted segment in mature B-cell lymphoid neoplasias with deletion of 7q. Genes Chromosomes Cancer (1997) 0.84
Cytogenetic analysis of the mononuclear cell component of giant cell tumors of bone. Cancer Genet Cytogenet (2003) 0.81
Cytogenetic analyses on giant-cell tumors of bone. Clin Orthop Relat Res (1989) 0.79
Significance of chromosomal abnormalities in a malignant giant cell tumor of bone. Cancer Genet Cytogenet (1991) 0.76
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature (2011) 13.18
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet (2011) 6.43
Zinc-finger transcription factor Slug contributes to the function of the stem cell factor c-kit signaling pathway. Blood (2002) 1.64
Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting. Blood (2009) 1.62
Cancer induction by restriction of oncogene expression to the stem cell compartment. EMBO J (2008) 1.52
Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays. Blood (2002) 1.44
SLUG in cancer development. Oncogene (2005) 1.42
Prognostic and biologic significance of chromosomal imbalances assessed by comparative genomic hybridization in multiple myeloma. Blood (2004) 1.26
Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice. Proc Natl Acad Sci U S A (2012) 1.19
Dido gene expression alterations are implicated in the induction of hematological myeloid neoplasms. J Clin Invest (2005) 1.18
Cancer development induced by graded expression of Snail in mice. Hum Mol Genet (2005) 1.18
Snail family transcription factors are implicated in thyroid carcinogenesis. Am J Pathol (2007) 1.17
A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitors. EMBO J (2012) 1.12
Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations. Br J Haematol (2013) 1.10
Essential role for telomerase in chronic myeloid leukemia induced by BCR-ABL in mice. Oncotarget (2012) 1.07
NIK controls classical and alternative NF-κB activation and is necessary for the survival of human T-cell lymphoma cells. Clin Cancer Res (2013) 0.99
Germinal centre protein HGAL promotes lymphoid hyperplasia and amyloidosis via BCR-mediated Syk activation. Nat Commun (2013) 0.98
Array comparative genomic hybridization identifies genetic regions associated with outcome in aggressive diffuse large B-cell lymphomas. Cancer (2009) 0.95
Adipose tissue mass is modulated by SLUG (SNAI2). Hum Mol Genet (2007) 0.95
P53 deletion may drive the clinical evolution and treatment response in multiple myeloma. Eur J Haematol (2009) 0.93
Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype. Am J Pathol (2012) 0.92
Goal orientations, motivational climate, equality, and discipline of Spanish physical education students. Percept Mot Skills (2004) 0.91
A new palliative care consultation team at the oncology department of a university hospital: an assessment of initial efficiency and effectiveness. Support Care Cancer (2012) 0.90
Bcl2 is not required for the development and maintenance of leukemia stem cells in mice. Carcinogenesis (2010) 0.89
Overexpression of the VAV proto-oncogene product is associated with B-cell chronic lymphocytic leukaemia displaying loss on 13q. Br J Haematol (2006) 0.89
Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-. Haematologica (2008) 0.88
Flow cytometry immunophenotyping of fine-needle aspiration specimens: utility in the diagnosis and classification of non-Hodgkin lymphomas. Histopathology (2011) 0.88
geneCBR: a translational tool for multiple-microarray analysis and integrative information retrieval for aiding diagnosis in cancer research. BMC Bioinformatics (2009) 0.88
Use of customized-mold brachytherapy in the management of malignancies arising in the maxillary antrum after maxillectomy: a dosimetric analysis. Brachytherapy (2010) 0.86
Onychomatricoma: genome-wide analyses of a rare nail matrix tumor. J Am Acad Dermatol (2010) 0.86
Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases. Am J Surg Pathol (2009) 0.85
Characterization of p87C3G, a novel, truncated C3G isoform that is overexpressed in chronic myeloid leukemia and interacts with Bcr-Abl. Exp Cell Res (2006) 0.84
The value of fluorescence in situ hybridization for the detection of 11q in multiple myeloma. Haematologica (2004) 0.84
Reciprocal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemias: review of 5,654 patients with an evaluable karyotype. Genes Chromosomes Cancer (2013) 0.83
Multicolor fluorescence in situ hybridization studies in multiple myeloma and monoclonal gammopathy of undetermined significance. Hematol J (2003) 0.83
Upregulation of Dicer is more frequent in monoclonal gammopathies of undetermined significance than in multiple myeloma patients and is associated with longer survival in symptomatic myeloma patients. Haematologica (2010) 0.82
Association between serum malondialdehyde levels and mortality in patients with severe brain trauma injury. J Neurotrauma (2015) 0.82
Molecular characterization of the region 7q22.1 in splenic marginal zone lymphomas. PLoS One (2011) 0.81
Expression of the FUS domain restores liposarcoma development in CHOP transgenic mice. Oncogene (2002) 0.80
Geographic differences in the incidence of cytogenetic abnormalities of acute myelogenous leukemia (AML) in Spain. Leuk Res (2006) 0.80
Pharmacodynamic behaviour of the selective cyclooxygenase-2 inhibitor lumiracoxib in the lipopolysaccharide-stimulated rat air pouch model. Eur J Pharm Sci (2005) 0.78
Imatinib therapy of chronic myeloid leukemia restores the expression levels of key genes for DNA damage and cell-cycle progression. Pharmacogenet Genomics (2012) 0.78
Chromosomal abnormalities are related to location and grade of osteoarthritis. Osteoarthritis Cartilage (2004) 0.77
Expression of VAV1 in the tumour microenvironment of glioblastoma multiforme. J Neurooncol (2012) 0.77
What is the best term in Spanish to express the concept of cancer-related fatigue? J Palliat Med (2009) 0.77
Heterogeneity of structural abnormalities in the 7q31.3 approximately q34 region in myeloid malignancies. Cancer Genet Cytogenet (2004) 0.77
Limbus damage in ocular graft-versus-host disease. Biol Blood Marrow Transplant (2010) 0.77
Novel compound heterozygous mutations in the SRD5A2 gene from 46,XY infants with ambiguous external genitalia. J Hum Genet (2008) 0.77
Toxicokinetic assessment of methylphenidate (Ritalin) in a 13-week oral toxicity study in dogs. Biomed Chromatogr (2004) 0.76
FISH analysis of hematological neoplasias with 1p36 rearrangements allows the definition of a cluster of 2.5 Mb included in the minimal region deleted in 1p36 deletion syndrome. Hum Genet (2005) 0.76
Automatic knowledge extraction in sequencing analysis with multiagent system and grid computing. J Integr Bioinform (2012) 0.76
Cloning and expression of the estrogen receptor-alpha (Esr1) from the Harderian gland of the sea turtle (Lepidochelys olivacea). Gen Comp Endocrinol (2009) 0.76
Aerobic exercise training programmes for improving physical and psychosocial health in adults with Down syndrome. Cochrane Database Syst Rev (2010) 0.75
Hematological, immunophenotypic, and cytogenetic characteristics of acute myeloblastic leukemia with trisomy 11. Cancer Genet Cytogenet (2005) 0.75
Laser-Induced Breakdown Spectroscopy (LIBS) Quality Control and Origin Identification of Handmade Manufactured Cigars. Appl Spectrosc (2015) 0.75
WITHDRAWN: Aerobic exercise training programmes for improving physical and psychosocial health in adults with Down syndrome. Cochrane Database Syst Rev (2009) 0.75
Quantification of methylphenidate (Ritalin) in rabbit fetal tissue using a chiral liquid chromatography/tandem mass spectrometry assay. Rapid Commun Mass Spectrom (2002) 0.75
Infectious esophagic fistula: A common virus with an extraordinary presentation. Rev Esp Enferm Dig (2013) 0.75
Clinical applications of BAC array-CGH to the study of diffuse large B-cell lymphomas. Methods Mol Biol (2013) 0.75
High-throughput determination of ultra-low concentrations of LAG078, a lipid modulator, in human plasma. J Pharm Biomed Anal (2005) 0.75
Identification of biological markers of sensitivity to high-clinical-risk-adapted therapy for patients with diffuse large B-cell lymphoma. Leuk Lymphoma (2009) 0.75
Extreme androgen resistance in a kindred with a novel insertion/deletion mutation in exon 5 of the androgen receptor gene. J Hum Genet (2003) 0.75
Genomic analysis of clonal eosinophils by CGH arrays reveals new genetic regions involved in chronic eosinophilia. Eur J Haematol (2014) 0.75
Middle aged male with recurrent episodes of confusion, aggressive behavior and loss of consciousness. Bol Asoc Med P R (2011) 0.75
Compound Property Optimization in Drug Discovery Using Quantitative Surface Sampling Micro Liquid Chromatography with Tandem Mass Spectrometry. Anal Chem (2016) 0.75
Transient t(11;17)(q14;q12) in patient with chronic myelogenous leukemia in complete molecular response. Cancer Genet Cytogenet (2008) 0.75
Integration of global spectral karyotyping, CGH arrays, and expression arrays reveals important genes in the pathogenesis of glioblastoma multiforme. Ann Surg Oncol (2012) 0.75